Werkgroep Cardiologische centra Nederland English

Publicaties: ACS acuut coronair syndroom

  • Alirocumab and Cardiovascular Outcomes after Acute Coronary SyndromeNEJM - ODYSSEY - ACS
  • Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial.J Am Coll Cardiol - Abstract - Alings, dr. A.M.W. - ODYSSEY - ACS
  • Inhibition of Interleukin-1b by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney DiseaseJ Am Coll Cardiol - Abstract - Cornel, dr. J.H. - CANTOS - ACS
  • Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.Lancet - Abstract - Alings, dr. A.M.W. - COMPASS - ACS
  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseaseN Engl J Med - Abstract - Cornel, dr. J.H. - CANTOS - ACS
  • Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.Can J Cardiol - Abstract - Alings, dr. A.M.W. - COMPASS - ACS
  • Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseN Engl J Med - Abstract - Alings, dr. A.M.W. - COMPASS - ACS
  • Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trialLancet - Abstract - Cornel, dr. J.H. - GEMINI - ACS
  • Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the NetherlandsBMJ Open - Abstract - Oude Ophuis, dr. A.J.M.; Umans, dr. V.A.M.C.; Oemrawsingh, dr. P.V.; Akkerhuis, dr. J.M.; Schotborgh, drs. C.E.; Ronner, dr. E.; Lenderink, dr. T.; Liem, dr. A.H.; The, dr. S.H.K.; Wardeh, dr. A.J.; Hermans, dr. W.R.M. - BIOMARCS - ACS
  • Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary SyndromesJournal of the American Heart Association - Cornel, dr. J.H. - Trilogy - ACS
  • Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction. The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)Circulation - Oude Ophuis, dr. A.J.M. - AEGIS - ACS
  • Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial.JAMA Cardiol. - Abstract - Oude Ophuis, dr. A.J.M. - PEGASUS TIMI54 - ACS
  • Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.J Am Coll Cardiol - Abstract - Cornel, dr. J.H. - TRA-CER - ACS
  • Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical TrialJAMA - Abstract - Oude Ophuis, dr. A.J.M. - LATITUDE - deel A - ACS
  • Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54Eur Heart J - Abstract - Oude Ophuis, dr. A.J.M. - PEGASUS TIMI54 - ACS
  • Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trialAm Heart J - Abstract - Cornel, dr. J.H. - Trilogy - ACS
  • Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial.Eur Heart J Acute Cardiovasc Care - Abstract - Cornel, dr. J.H. - Trilogy - ACS
  • Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial.Am Heart J - Abstract - Boven, dr. A.J. van - PLATO - ACS
  • Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesN Engl J Med - Abstract - Kuijper, dr. A.F.M. - Improve-IT - ACS
  • Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).Am J Cardiol - Abstract - Cornel, dr. J.H. - TRA-CER - ACS
  • Long-term use of ticagrelor in patients with prior myocardial infarctionN Engl J Med - Abstract - Kuijper, dr. A.F.M.; Oude Ophuis, dr. A.J.M. - PEGASUS TIMI54 - ACS
  • Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial.Am Heart J - Abstract - Cornel, dr. J.H. - APPRAISE-2 - ACS
  • The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial.Eur Heart J Acute Cardiovasc Care - Abstract - Oude Ophuis, dr. A.J.M.; Hessen, dr. M.W.J. van - ATLAS-2 - ACS
  • Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trialJAMA - Abstract - Kuijper, dr. A.F.M. - SOLID TIMI52 - ACS
  • Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial.Am Heart J - Abstract - Cornel, dr. J.H. - Trilogy - ACS
  • Darapladib for preventing ischemic events in stable coronary heart diseaseN Engl J Med - Abstract - Kuijper, dr. A.F.M. - Stability LPL II - ACS
  • Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy.Thromb Haemost - Abstract - Cornel, dr. J.H. - TRA-CER - ACS
  • Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.JAMA - Abstract - Cornel, dr. J.H. - Trilogy - ACS
  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularizationN Engl J Med - Abstract - Kuijper, dr. A.F.M. - Trilogy - ACS
  • Apixaban after acute coronary syndrome in patients with heart failure: insights from the APPRAISE-2 trial.Eur Heart J - Cornel, dr. J.H. - APPRAISE-2 - ACS
  • Distal embolic protection during percutaneous coronary intervention in patients with acute coronary syndromes: the RUBY study.Acute Card Care - Abstract - Suryapranata, H. [inactief] - RUBY I - ACS

Publicaties per WCN-studie

Publicaties WCN-studies per WCN-lid